- Home
- SARS-CoV-2 Omicron Spike Antigens
- SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO)
The Native Antigen
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO)
- SKU:
- REC32009
- UPC:
- MPN:
Description
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO) | REC32009 from Native Antigen is available for delivery.
SARS-CoV-2 Omicron Spike (CHO) protein. Recombinant SARS-CoV-2 Spike protein S1 (A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H) expressed in CHO cells. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
PRODUCT DETAILS – SARS-COV-2 (B.1.1.529/OMICRON) SPIKE GLYCOPROTEIN (S1), HIS-TAG (CHO)
- SARS-CoV-2 Omicron Spike (CHO), Accession: MN908947
- SARS-CoV-2 (B.1.1.529/Omicron) spike contains A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H mutations relative to Wuhan Hu-1.
- Expressed in CHO cells and purified by affinity chromatography.
- Presented in liquid form in DPBS.
BACKGROUND
South Africa reported the identification of a new SARS-CoV-2 variant, B.1.1.529, to the World Health Organization (WHO) on November 24, 2021. B.1.1.529 was first detected in specimens collected in Botswana and South Africa. On December 1, 2021, the first case attributed to B.1.1.529 was reported in the United States in a person who returned from travel to South Africa. The Omicron variant has since been detected in travel-related cases in an increasing number of European countries, as well as Australia, Brazil, Canada, Hong Kong, Israel, Japan, Nigeria, Norway, Sweden, and the United Kingdom. A few countries, including the United States, have reported cases in individuals without travel history to southern Africa.
On November 26, 2021, the Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) convened to assess B.1.1.529. The TAG-VE advised WHO that this variant should be designated as a Variant of Concern (VOC), and WHO designated B.1.1.529 as a VOC named Omicron. The European Center for Disease Prevention and Control also classified this variant as a VOC due to concerns regarding immune escape and potentially increased transmissibility compared to the Delta variant.
Omicron has a large number of spike protein substitutions, some of which are known from other variants to be associated with reduced susceptibility to available monoclonal antibody therapeutics or reduced neutralization by convalescent and vaccinee sera. The spike protein of the Omicron variant is characterized by at least 30 amino acid substitutions, three small deletions, and one small insertion. Notably, 15 of the 30 amino acid substitutions are in the receptor binding domain (RBD). There are also a number of changes and deletions in other genomic regions. Some diagnostic kits have significantly reduced S-gene target sensitivity due to the deletion at H69 and V70 in the B Omicron spike protein. Specimens being tested using these kits that yield an S gene target failure (SGTF) ‘may’ be Omicron (CDC, 2021).
REFERENCES
- Science Brief: Omicron (B.1.1.529) Variant (CDC).
- Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern (WHO).
- Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA (ECDC).
Related Products

Recombinant SARS-CoV-2 Spike S1 Protein with His-Tag | E80004
EpiGentek

SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
The Native Antigen

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
The Native Antigen

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
The Native Antigen

SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) | S-CP-P2010
Elabscience
Customers Also Viewed

SARS-CoV-2 Y14 | GEN-P0DTD3
Gentaur

SARS-CoV-2 M | GEN-P0DTC5
Gentaur

SARS-CoV-2 E | GEN-P0DTC4
Gentaur

SARS-CoV-2 N | GEN-P0DTC9
Gentaur

SARS-CoV-2 N | S-CP-P2009
Elabscience

SARS-CoV-2 M | S-CP-P2008
Elabscience

SARS-CoV-2 Spike Glycoprotein-crude | S-CP-P2007
Elabscience

SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) | S-CP-P2010
Elabscience

HCoV-229E Spike Glycoprotein | GEN-P15423
Gentaur

Recombinant SARS-CoV-2 NSP16 protein | 763-PKSV030330
Elabscience

Recombinant SARS-CoV-2 NSP12 protein | 763-PKSV030327
Elabscience

Recombinant SARS-CoV-2 S+E+M protein | 763-PKSV030324
Elabscience

Recombinant SARS-CoV-2 S-trimer 6P Protein | 763-PKSV030323
Elabscience

Recombinant SARS-CoV-2 S-trimer Protein | 763-PKSV030322
Elabscience

CleanPlex SARS-CoV-2 Panel (384) | 918012
BioServUK

CleanPlex SARS-CoV-2 Panel (96) | 918011
BioServUK

CleanPlex SARS-CoV-2 Panel (8) | 918010
BioServUK

CleanPlex for MGI SARS-CoV-2 Panel (384) | 918003
BioServUK

Biotinylated Detection Affimer Reagent | BSV-COV-DET-05
BioServUK

Capture Affimer Reagent 2 | BSV-COV-CA03
BioServUK

Capture Affimer Reagent 1 | BSV-COV-CA01
BioServUK


SARS-CoV-2 S1 Protein Antibody | abx229485
abbexa


SARS-CoV-2 Spike Glycoprotein Antibody | abx226551
abbexa


SARS-CoV-2 Spike Glycoprotein Antibody | abx243126
abbexa


SARS-CoV-2 Spike Glycoprotein Antibody | abx243125
abbexa


SARS-CoV-2 Spike Glycoprotein Antibody | abx376479
abbexa


SARS-CoV-2 Spike Glycoprotein RBD Antibody Pair | abx243136
abbexa

Biovision | Human CellExp™ SARS-CoV-2 Spike RBD (L452R, T478K), Recombinant | P1744
Biovision

Biovision | Human CellExp™ SARS-CoV-2 S1 Protein (Delta Plus), Recombinant | P1677
Biovision
xNetic™ Viral DNA/RNA Extraction Kit
LaunchWorks

Recombinant Human Novel Coronavirus Spike glycoprotein(S) | CSB-YP3324GMYa4
Cusabio

Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-YP3324GMY1
Cusabio

Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-MP3324GMY1b1
Cusabio

Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-MP3324GMY1
Cusabio

Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-MP3324GMY
Cusabio

pPACK-SPIKE™ Beta (B.1.351), SARS-CoV-2 "S" Pseudotype - Beta (B.1.351) Variant - Lentivector Packaging Mix (XL) | CVD19-645A-1
SBI System Biosciences

pPACK-SPIKE™ B.1.525, SARS-CoV-2 "S" Pseudotype - B.1.525 Variant - Lentivector Packaging Mix | CVD19-620A-1
SBI System Biosciences

HEK293 "N" SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line | CVD19-220A-1
SBI System Biosciences

SARS-CoV-2 Spike Glycoprotein Expression (S) Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Plasmid) | CVD19-130PA-1
SBI System Biosciences

SARS-CoV-2 S Recombinant Antibody, HRP Conjugated | A73673
EpiGentek

SARS-CoV-2 S Recombinant Antibody, FITC Conjugated | A73674
EpiGentek

SARS-CoV-2 S Recombinant Antibody | A73670
EpiGentek

Recombinant SARS-CoV-2 Spike S1 Protein with His-Tag | E80004
EpiGentek

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2), Recombinant | P1547
Biovision

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; S1), Recombinant | P1524
Biovision

SARS Nucleocapsid protein, His Tag | NUN-S5229
Acro Biosystems

MERS Nucleocapsid protein, His Tag | NUN-M52H5
Acro Biosystems

HRP-SARS-CoV-2 Spike Trimer, His Tag | SPN-CR2H5
Acro Biosystems

HRP-SARS-CoV-2 Spike Trimer, His Tag | SPN-CR2H4
Acro Biosystems

HCoV-OC43 Nucleocapsid protein, His Tag | NUN-V5145
Acro Biosystems